Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Markets Investing.com By Reuters 11 Jun 2026 06:06 1 min read

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.